[OhioDAN-Talk] FW: [Diabetes-Talk] metformin recall

[Walter Mitchell]

Good Morning Ohio Diabetics, Family and Friends;

The previous messages are for your information. Please conduct your research
and talk with your doctor and pharmacist prior to making a change in your
medication. As indicated below, the manufacturers involved represent a small
percentage of the manufacturers of metformin.

Again, I submit that this is FYI. If you take this medicine, do your
research!

Sincerely,
Walter Mitchell


-----Original Message-----
From: Diabetes-Talk [mailto:diabetes-talk-bounces at nfbnet.org] On Behalf Of
Pratik Patel via Diabetes-Talk
Sent: Tuesday, June 30, 2020 12:08 AM
To: 'Diabetes Talk for the Blind'; 'Peter Youssef'
Cc: Pratik Patel
Subject: Re: [Diabetes-Talk] metformin recall

Here is the actual text of the press release. Note that the  recall is for
certain batches and applies to ER Metformin by a few manufacturers. Read to
the end to see note about prescriptions and what you should do.

FDA is alerting patients and health care professionals to five companies'
voluntary recalls of certain extended release (ER) metformin drugs. The
agency recently announced it was in contact with five companies to recommend
they voluntarily recall ER metformin because the agency's testing showed
N-Nitrosodimethylamine (NDMA) above the acceptable intake limit in certain
lots.
. Apotex - All lots
. Amneal - All lots
. Marksans (labeled as Time-Cap) - One lot (XP9004)
. Lupin - One lot (G901203)
. Teva (labeled as Actavis) - 14 lots
There are additional companies that manufacturer ER metformin and supply a
significant portion of the U.S. market, whose products are not being
recalled at this time.
Patients taking recalled ER metformin should continue taking it until a
doctor or pharmacist gives them a replacement or a different treatment
option. It could be dangerous for patients with type 2 diabetes to stop
taking their metformin without first talking to their health care
professional. FDA recommends that health care professionals continue to
prescribe metformin when clinically appropriate; FDA testing has not shown
NDMA in immediate release (IR) metformin products (the most commonly
prescribed type of metformin).

Source:
https://www.fda.gov/drugs/drug-safety-and-availability/fda-updates-and-press
-announcements-ndma-metformin
-----Original Message-----
From: Diabetes-Talk <diabetes-talk-bounces at nfbnet.org> On Behalf Of Jude
DaShiell via Diabetes-Talk
Sent: Monday, June 29, 2020 11:52 PM
To: Peter Youssef <kingtut41 at gmail.com>
Cc: Jude DaShiell <jdashiel at panix.com>; diabetes-talk at nfbnet.org
Subject: Re: [Diabetes-Talk] metformin recall

https://www.healthline.com/health-news/fda-asks-companies-to-recall-
   diabetes-medication-metformin-over-cancer-causing-chemical



-- 


_______________________________________________
Diabetes-Talk mailing list
Diabetes-Talk at nfbnet.org
http://nfbnet.org/mailman/listinfo/diabetes-talk_nfbnet.org
To unsubscribe, change your list options or get your account info for
Diabetes-Talk:
http://nfbnet.org/mailman/options/diabetes-talk_nfbnet.org/pratikp1%40gmail.
com


_______________________________________________
Diabetes-Talk mailing list
Diabetes-Talk at nfbnet.org
http://nfbnet.org/mailman/listinfo/diabetes-talk_nfbnet.org
To unsubscribe, change your list options or get your account info for
Diabetes-Talk:
http://nfbnet.org/mailman/options/diabetes-talk_nfbnet.org/walterl.mitch2%40
gmail.com